Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Lawmakers and ag industry groups welcomed the confirmations, citing the direct impact of these leaders on western ranchers, water and land management, conservation programs, and regulatory reform.
All eyes will be on today’s Cattle on Feed Report, which analysts say could give a clearer picture of where the market goes next.
More than 100 pork producers traveled to Washington to meet with lawmakers and underscore the threat to small family farms.
Now the Senate must pass a version of the spending bill before the Sept. 30 deadline.
